ANIP News and Press, ANI Pharmaceuticals Inc. From 05/29/24

BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows: To schedule a 1x1 meetin...

BAUDETTE, Minn., May 20, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Kionex ® (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use. Kionex ® Suspension is the only commercially available ...

2024-05-19 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-10 14:14:13 ET ANI Pharmaceuticals, Inc. (ANIP) Q1 2024 Earnings Conference Call May 10, 2024, 8:30 AM ET Company Participants Lisa Wilson - In-Site Communications, Investor Relations Nikhil Lalwani - President and Chief Executive Officer Stephen Carey - ...

Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...

Generated record quarterly net revenues of $137.4 million, representing year-over-year growth of 28.7% , net income to common shareholders of $17.8 million, and GAAP diluted earnings per share of $0.82 Delivered record adjusted non-GAAP EBITDA of $3...

2024-05-09 12:40:31 ET More on ANI Pharmaceuticals ANI Pharmaceuticals, Inc. (ANIP) Q4 2023 Earnings Call Transcript ANI Pharmaceuticals Non-GAAP EPS of $1.00, revenue of $131.7M Seeking Alpha’s Quant Rating on ANI Pharmaceuticals Historical earnings d...

2024-05-09 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2024 financial results on Friday, May 10, 2024, prior to the market open. Nikhil ...

2024-04-09 16:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...